UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000040771
Receipt No. R000046558
Scientific Title Comparison of the oncological outcomes of stenting as a bridge to surgery and surgery alone in obstructive colorectal cancer; a retrospective study
Date of disclosure of the study information 2020/06/15
Last modified on 2020/06/15 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study on the effectiveness of stenting for obstructive colorectal cancer at Niigata City Hospital
Acronym Study of stenting for obstructive colorectal cancer
Scientific Title Comparison of the oncological outcomes of stenting as a bridge to surgery and surgery alone in obstructive colorectal cancer; a retrospective study
Scientific Title:Acronym Comparison stenting as a bridge to surgery and surgery alone in obstructive colorectal cancer
Region
Japan

Condition
Condition Obstructive colorectal cancer
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 We evaluated the oncological outcomes of bridge to surgery (BTS) using a self-expanded metallic stent (SEMS) compared with surgery alone for obstructive colorectal cancer.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Postoperative recurrence rate through 8 years after introduction of colorectal stent at Niigata City General Hospital.
Key secondary outcomes the short-term surgical outcome, survival rate, recurrence sites.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Patients who underwent curative resection for obstructive colorectal cancer at Niigata City General Hospital were divided into the bridge to surgery with stenting group (treated from April 2012, when stenting for malignant bowel obstruction was covered by insurance in Japan, to 2019) and the surgery alone group (treated from 2008 to 2019).
The surgery alone group included patients who did not undergo decompression and patients who underwent non-surgical bowel decompression at the oral side of obstructive colorectal cancer and had a nasal ileus tube or nasogastric tube placed before curative resection.
In this study, obstructive colorectal cancer was diagnosed by computed tomography (CT) and colonoscopy in which urgent decompression was deemed necessary.
Key exclusion criteria The patients who underwent preoperative bowel decompression procedures by trans-anal tube or stoma creation at the oral side of the cancer were excluded.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Hiroaki
Middle name
Last name Uehara
Organization Niigata City General Hospital
Division name Department of Digestive Surgery
Zip code 950-1197
Address 463-7, Shumoku, Chuo-ku, Niigata City, Niigata, Japan.
TEL +81-25-281-5151
Email hiroaki.u@hotmail.co.jp

Public contact
Name of contact person
1st name Hiroaki
Middle name
Last name Uehara
Organization Niigata City General Hospital
Division name Department of Digestive Surgery
Zip code 950-1197
Address 463-7, Shumoku, Chuo-ku, Niigata City, Niigata, Japan.
TEL +81-25-281-5151
Homepage URL
Email hiroaki.u@hotmail.co.jp

Sponsor
Institute Niigata City General Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Niigata City General Hospital
Address 463-7, Shumoku, Chuo-ku, Niigata City, Niigata, Japan.
Tel +81-25-281-5151
Email hiroaki.u@hotmail.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 85
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 04 Month 19 Day
Date of IRB
2020 Year 04 Month 20 Day
Anticipated trial start date
2020 Year 04 Month 20 Day
Last follow-up date
2020 Year 04 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information None

Management information
Registered date
2020 Year 06 Month 15 Day
Last modified on
2020 Year 06 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046558